Table 4.
Multinomial logistic regression for the association between ED and HCY, B12 and FA
HCY | Binary HCY | B12 | FA | |||||||||
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
ED—unadjusted | ||||||||||||
None (IIEF-5=22–25) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Mild (17–21) | 1.081 | 0.695 to 1.681 | 0.730 | 1.246 | 0.980 to 1.583 | 0.072 | 1.694 | 1.207 to 2.376 | 0.002 | 1.180 | 0.801 to 1.740 | 0.402 |
Moderate (12–16) | 1.258 | 0.649 to 2.439 | 0.497 | 1.298 | 0.896 to 1.880 | 0.168 | 1.187 | 0.715 to 1.972 | 0.508 | 0.960 | 0.519 to 1.776 | 0.896 |
Severe (5–11) | 1.259 | 0.562 to 2.820 | 0.575 | 1.258 | 0.799 to 1.980 | 0.322 | 0.891 | 0.496 to 1.599 | 0.698 | 0.923 | 0.434 to 1.963 | 0.834 |
ED—age adjusted | ||||||||||||
None (IIEF-5=22–25) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Mild (17–21) | 0.948 | 0.607 to 1.480 | 0.814 | 1.166 | 0.914 to 1.486 | 0.217 | 1.596 | 1.135 to 2.244 | 0.007 | 1.052 | 0.710 to 1.558 | 0.800 |
Moderate (12–16) | 0.929 | 0.455 to 1.898 | 0.840 | 1.095 | 0.747 to 1.605 | 0.643 | 1.409 | 0.635 to 1.733 | 0.851 | 0.762 | 0.404 to 1.437 | 0.401 |
Severe (5–11) | 1.068 | 0.467 to 2.443 | 0.876 | 1.150 | 0.726 to 1.820 | 0.552 | 0.839 | 0.471 to 1.495 | 0.551 | 0.794 | 0.370 to 1.705 | 0.554 |
ED—multivariate adjusted | ||||||||||||
None (IIEF-5=22–25) | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Mild (17–21) | 0.973 | 0.621 to 1.524 | 0.904 | 1.188 | 0.929 to 1.517 | 0.169 | 1.620 | 1.141 to 2.300 | 0.007 | 1.184 | 0.775 to 1.808 | 0.435 |
Moderate (12–16) | 0.965 | 0.472 to 1.971 | 0.922 | 1.119 | 0.762 to 1.643 | 0.567 | 0.972 | 0.576 to 1.640 | 0.915 | 0.777 | 0.401 to 1.507 | 0.456 |
Severe (5–11) | 1.132 | 0.491 to 2.613 | 0.771 | 1.187 | 0.748 to 1.885 | 0.467 | 0.717 | 0.388 to 1.324 | 0.288 | 0.821 | 0.368 to 1.831 | 0.631 |
Binary HCY: normal HCY (5–15 µmol/L); hyperhomocysteinaemia (>15 µmol/L). The categorical dependent variables were the various ED groups, based on the IIEF-5. The symptoms of ED were divided into None (IIEF-5=22–25), Mild (17–21), Moderate (12–16) and Severe (5–11). The None group (22–25) was treated as the reference. Multivariate adjusted: age, BMI, WHR, smoke and drink.
BMI, body mass index; B12, vitamin B12; ED, erectile dysfunction; FA, folic acid; HCY, homocysteine; IIEF-5, International Index of Erectile Function; WHR, waist:hip ratio.